JP2022510007A5 - - Google Patents

Info

Publication number
JP2022510007A5
JP2022510007A5 JP2021531637A JP2021531637A JP2022510007A5 JP 2022510007 A5 JP2022510007 A5 JP 2022510007A5 JP 2021531637 A JP2021531637 A JP 2021531637A JP 2021531637 A JP2021531637 A JP 2021531637A JP 2022510007 A5 JP2022510007 A5 JP 2022510007A5
Authority
JP
Japan
Application number
JP2021531637A
Other languages
Japanese (ja)
Other versions
JP2022510007A (ja
JPWO2020117564A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063351 external-priority patent/WO2020117564A1/en
Publication of JP2022510007A publication Critical patent/JP2022510007A/ja
Publication of JPWO2020117564A5 publication Critical patent/JPWO2020117564A5/ja
Publication of JP2022510007A5 publication Critical patent/JP2022510007A5/ja
Priority to JP2024153896A priority Critical patent/JP2024170568A/ja
Pending legal-status Critical Current

Links

JP2021531637A 2018-12-03 2019-11-26 大型薬物の送達改善 Pending JP2022510007A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024153896A JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862774677P 2018-12-03 2018-12-03
US62/774,677 2018-12-03
US201962789407P 2019-01-07 2019-01-07
US62/789,407 2019-01-07
US201962808274P 2019-02-20 2019-02-20
US62/808,274 2019-02-20
PCT/US2019/063351 WO2020117564A1 (en) 2018-12-03 2019-11-26 Improved delivery of large agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024153896A Division JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Publications (3)

Publication Number Publication Date
JP2022510007A JP2022510007A (ja) 2022-01-25
JPWO2020117564A5 JPWO2020117564A5 (https=) 2022-12-05
JP2022510007A5 true JP2022510007A5 (https=) 2022-12-05

Family

ID=68966029

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531637A Pending JP2022510007A (ja) 2018-12-03 2019-11-26 大型薬物の送達改善
JP2024153896A Pending JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024153896A Pending JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Country Status (12)

Country Link
US (1) US20220031595A1 (https=)
EP (1) EP3890704A1 (https=)
JP (2) JP2022510007A (https=)
KR (1) KR20210102301A (https=)
CN (2) CN113423381A (https=)
AU (2) AU2019391791A1 (https=)
BR (2) BR112021009554A2 (https=)
CA (1) CA3119043A1 (https=)
IL (1) IL283627A (https=)
MX (2) MX2021006102A (https=)
SG (1) SG11202104838SA (https=)
WO (1) WO2020117564A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US12599625B2 (en) 2021-05-13 2026-04-14 Penland Foundation Treatment of ARDS and other conditions caused by acutely elevated cytokine levels and post ARDS chronic cytokine production using inhaled anesthetics
WO2023287726A1 (en) 2021-07-12 2023-01-19 Penland Foundation Treatment of cancer using botulinum toxin and nitrous oxide
KR20230024669A (ko) * 2021-08-12 2023-02-21 주식회사 페로카 마이크로니들 패치
CN114191376B (zh) * 2022-01-05 2024-03-01 中国药科大学 一种用于治疗阿尔兹海默症的微针贴片及其制备方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US296006A (en) 1884-04-01 John hoefleb
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US6939852B2 (en) 1991-09-24 2005-09-06 Allergan, Inc. Methods and compositions for the treatment of cerebral palsy
US7384918B2 (en) 1991-09-24 2008-06-10 Allergan, Inc. Botulinum toxin for treating muscle contracture
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5512547A (en) 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5965154A (en) 1998-03-17 1999-10-12 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
CN101160318A (zh) 2005-03-03 2008-04-09 雷文斯治疗公司 用于局部施用和经皮肤递送寡肽的组合物和方法
JP2009527275A (ja) * 2006-02-17 2009-07-30 ゾゲニクス インコーポレーティッド 神経毒の送達のための方法およびシステム
EP2015773A4 (en) 2006-04-27 2010-05-05 Anterios Inc EXAMINATION OF THE EFFECTS OF TOPICAL ADMINISTRATION OF CHEMICALLY DENOMINATING PHARMACEUTICALS
US20120150023A1 (en) 2007-08-06 2012-06-14 Kaspar Roger L Microneedle arrays for active agent delivery
MX379265B (es) * 2008-06-26 2025-03-11 Anterios Inc Aplicacion dérmica de toxina botulínica en nanoemulsiones para usarse en el tratamiento de trastornos de la piel.
WO2010056922A2 (en) * 2008-11-12 2010-05-20 Kythera Biopharmaceuticals, Inc. Systems and methods for delivery of biologically active agents
JP2012509106A (ja) * 2008-11-18 2012-04-19 スリーエム イノベイティブ プロパティズ カンパニー 中空のマイクロニードルアレイ及び方法
AU2009332947C1 (en) 2008-12-31 2019-01-03 Revance Therapeutics, Inc. Injectable botulinum toxin formulations
EP2575872B1 (en) * 2010-06-01 2020-08-19 Seqirus UK Limited Concentration of influenza vaccine antigens without lyophilization
KR20140005998A (ko) 2011-01-24 2014-01-15 안테리오스, 인코퍼레이티드 나노입자 조성물, 이의 제형, 및 그의 용도
EP2667854B1 (en) 2011-01-24 2019-01-16 Anterios, Inc. Nanoparticle compositions
WO2013096026A1 (en) 2011-12-21 2013-06-27 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
EP3068423B8 (en) * 2013-11-12 2026-03-25 Healis Therapeutics, Inc. Treatment of panic disorder using botulinum toxin
AU2015253045B2 (en) * 2014-04-30 2020-07-16 Allergan, Inc. Formulations of biologics for intravesical instillation
US20170209553A1 (en) * 2016-01-22 2017-07-27 Transderm, Inc. Delivery of botulinum with microneedle arrays
US20210301289A1 (en) * 2016-07-29 2021-09-30 Roger L. Kaspar Methods of treating osmidrosis
AU2017360346B2 (en) * 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
CN107320841A (zh) * 2017-08-03 2017-11-07 党明 一种高分子微针及其制备方法和应用

Similar Documents

Publication Publication Date Title
BR112021020990A2 (https=)
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021016821A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
JP2022510007A5 (https=)
BR112019016138A2 (https=)
BR112019016142A2 (https=)
BR112021017234A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
AT524962A5 (https=)
BR112019016136A2 (https=)
BR102019023359A2 (https=)
BR112021013854A2 (https=)